The Microbial Sequencing Centers provide rapid and cost-effective production of high-quality, microbial genome sequences of microorganisms considered agents of bioterrism (Categories A, B, and C), related organisms, clinical isolates, closely related species, and invertebrate vectors of disease and microorganisms responsible for emerging and re-emerging infectious diseases for the scientific community.
NIAID will not accept unsolicited grant applications for large-scale DNA sequencing projects for microorganisms and invertebrate vectors of disease, including NIH cooperative agreement grant applications, which is a change in NIAID policy, effective December 2003. Investigators wishing to apply for support to sequence an organism not described above must do so in the context of an investigator-initiated, hypothesis-driven, unsolicited research project application (R01).
Centers
Contracts for Microbial Genome Sequencing Centers have been awarded to the J. Craig Venter Institute (JCVI) (non-government link) and the Broad Institute (non-government link).
Information for investigators requesting DNA sequencing
NIAID process for selecting sequencing projects
Guiding principles for making data available
A list of current NIAID-supported sequencing projects
A list of completed NIAID-supported sequencing projects
Information on the NIAID-funded project, including collaborators and viral samples being sequenced
Information on the NIAID and NHGRI collaborative project, including target selection process and projects
back to top